Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
University of Medicine & Dentistry of NJ
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PIC1 pre-clinical formulation and optimization as a novel anti-inflammatory pharmacological agent
The Diagnosis and Treatment of Critical Illness Polyneuromyopathy in Patients wit
Biomedical Tech
Inspiratory Muscle Activation via High Frequency Spinal Cord Stimulation
Covalent and Transition State Inhibitor Design
Recently added grants:
Identifying mechanisms that detect and eliminate aneuploid cells
Auditory Mechanics and the Cochlear Amplifier 2020
A versatile 'pan-spike-in' internal reference genome methodology for quantitative ChIP-seq normalization
Generation of Novel Osteolineage VHL Conditional Knockout Mice to Study B Cell Microenvironments
Use of super-resolution microscopy to visualize the interaction between Alzheimer therapeutic antibodies and A? aggregates
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005126-003
Application #
7191425
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2005
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Ge
Lynch, Patrick M. / University of Texas MD Anderson Cancer Center
$3,251,125
Publications
Lynch, Patrick M; Ayers, Gregory D; Hawk, Ernie et al.
(2010)
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Am J Gastroenterol 105:1437-43
Comments
Be the first to comment on this grant